-
*Etsushi TAKAHASHI
Consortium for Safety Assessment using Human iPS Cells Toyama Chemical Co., Ltd
-
Kaori MIYAMOTO
Consortium for Safety Assessment using Human iPS Cells Toyama Chemical Co., Ltd
-
Kaoru MORIMURA
Consortium for Safety Assessment using Human iPS Cells Toyama Chemical Co., Ltd
-
Yuta MORIYAMA
Consortium for Safety Assessment using Human iPS Cells Mochida Pharmaceutical Co., Ltd.
-
Sanae MAEDA
Consortium for Safety Assessment using Human iPS Cells Japan iPS Cardiac Safety Assessment Eisai Co., Ltd.
-
Tomohiko TANIGUCHI
Consortium for Safety Assessment using Human iPS Cells Japan iPS Cardiac Safety Assessment Eisai Co., Ltd.
-
Norimasa MIYAMOTO
Consortium for Safety Assessment using Human iPS Cells Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-Clinical Evaluation Expert Committee Japan iPS Cardiac Safety Assessment Eisai Co., Ltd.
-
Masakazu ISHIMURA
Consortium for Safety Assessment using Human iPS Cells Kaken Pharmaceutical Co., Ltd.
-
Maya MORITA
Consortium for Safety Assessment using Human iPS Cells Takeda Pharmaceutical Company Limited
-
Daisuke SAJI
Consortium for Safety Assessment using Human iPS Cells NISSEIBILIS Co., Ltd.
-
Hiroki OHNAKA
Consortium for Safety Assessment using Human iPS Cells NISSEIBILIS Co., Ltd.
-
Hiroyuki TASHIBU
Consortium for Safety Assessment using Human iPS Cells Japan iPS Cardiac Safety Assessment Ina Research Inc.
-
Masao OGUCHI
Consortium for Safety Assessment using Human iPS Cells Japan iPS Cardiac Safety Assessment Ina Research Inc.
-
Daiju YAMAZAKI
Japan iPS Cardiac Safety Assessment National Institute of Health Sciences
-
Yasunari KANDA
Japan iPS Cardiac Safety Assessment National Institute of Health Sciences
-
Yuko SEKINO
Japan iPS Cardiac Safety Assessment National Institute of Health Sciences
-
Takashi KITAGUCHI
Consortium for Safety Assessment using Human iPS Cells Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee Non-Clinical Evaluation Expert Committee Mochida Pharmaceutical Co., Ltd.
